In addition, histone deacetylase 4 (HDAC4), known to have critical roles in cancer development, is proved to be targeted and regulated by miR-22, indicating that downregulation of miR-22 may involve in HCC carcinogenesis and progression through potentiation of HDAC4 expression. The gene discussed is HDAC4; the disease is hepatocellular carcinoma.